Mizuho Securities analyst Vamil Divan maintained a Buy rating on Pfizer (PFE) today and set a price target of $43.00. The company’s shares closed last Thursday at $37.43.
According to TipRanks.com, Divan is ranked 0 out of 5 stars with an average return of -3.5% and a 41.6% success rate. Divan covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Satsuma Pharmaceuticals, and Revance Therapeutics.
Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $41.21, implying an 11.1% upside from current levels. In a report issued on October 16, RBC Capital also maintained a Buy rating on the stock with a $43.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $40.97 and a one-year low of $27.88. Currently, Pfizer has an average volume of 24.36M.
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PFE in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Read More on PFE:
